Samil Pharmaceutical Non-Registered Executive Yoo Dam-hyang Increases Stake by 1,000 Shares via On-Market Purchase

Samil Pharmaceutical non-registered executive Yoo Dam-hyang acquired 1,000 common shares at 6,010 KRW per share through on-market purchase on June 30, 2026, increasing total holdings to 13,000 shares.
This represents a minor stake change of 0.06% relative to total outstanding shares of 21,691,811, with negligible impact on management control or stock price.
As of the reporting date, the stake remains at 0.06% unchanged from the previous report, with no changes in convertible bonds or warrants.
[AI Summary]This filing is a routine insider transaction confirming a small open market purchase by an executive. The scale is insignificant, unrelated to capital raising or corporate events, and carries no stock price or investment risk implications.